Beam Therapeutics Inc. (BEAM)

BEAM trades at $22.97, 14.8% above the near-term max pain of $20 expiring Oct 17, 2025 (19 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is stable across expirations ($16-$24), indicating stable market expectations. Key magnetic zone at 20 where 5 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for BEAM shows stable levels around 20.00, reflecting balanced market expectations. The 40% spread signals divergent expectations across timeframes. Most levels below 22.97 may cap rallies. Strong magnetic level at 20 (5 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.